AbbVie
ABBV
#28
Rank
โ‚น26.049 T
Marketcap
โ‚น14,726
Share price
0.76%
Change (1 day)
5.21%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2024 (TTM): โ‚น305.05 Billion

According to AbbVie's latest financial reports the company's current earnings are โ‚น56.33 Billion. a decrease over its 2023 earnings that were of โ‚น532.03 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2024

Annual earnings

Year Earnings Change
2024 โ‚น316.32 B-40.54%
2023 โ‚น532.03 B-53.62%
2022 โ‚น1.147 T3.76%
2021 โ‚น1.105 T282.25%
2020 โ‚น289.25 B-59.67%
2019 โ‚น717.26 B62.13%
2018 โ‚น442.39 B-32.74%
2017 โ‚น657.76 B-1.99%
2016 โ‚น671.12 B18.65%
2015 โ‚น565.65 B180.5%
2014 โ‚น201.66 B-55.57%
2013 โ‚น453.88 B-6.86%
2012 โ‚น487.33 B56.05%
2011 โ‚น312.28 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚น945.99 B 199.06%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น713.27 Billion-325.48%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.079 T 241.24%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น392.34 B 24.03%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น58.73 B-81.43%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น162.24 B-48.71%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น374.08 B 18.26%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น888.10 B 180.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น43.69 B-86.19%๐Ÿ‡บ๐Ÿ‡ธ USA